People · Operator
Named in public records as an officer, director or promoter · active 2015–2019 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| MDNA Life Sciences, Inc. | — | Biotechnology | Pre-Seed | $1.2M | $25.9M | 2015 |
| Nexgen Forensic Sciences, Inc. | — | Biotechnology | Pre-Seed | $771K | $24.9M | 2018 |
Peter McKenney at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Peter McKenney on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Andrew Feldman | 1 | 5 |
| David Weitz | 1 | 4 |
| Christopher Hill | 1 | 3 |
| Jennifer Creed | 1 | 2 |
| Harry Smart | 1 | 2 |
| Robert Poulter | 1 | 2 |
| Robert Thayer | 1 | 2 |
| Jeffrey Lin | 1 | 2 |
| Chris Mitton | 1 | 1 |
| Andrew Harbottle | 1 | 1 |
| George Steinfels | 1 | 1 |
| Robert Boxer | 1 | 1 |
| Anthony Cantone | 1 | 1 |
| Joely Gardner | 1 | 1 |
| Christopher Mitton | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.